Skip to main content
Top
Published in: Medical Oncology 1/2011

01-12-2011 | OriginalPaper

MUC2 and MUC6 apomucins expression in human gastric neoplasm: an immunohistochemical analysis

Authors: Abdul-Zaher M. Khattab, Wesam A. Nasif, Mahmoud Lotfy

Published in: Medical Oncology | Special Issue 1/2011

Login to get access

Abstract

Apomucins play important biological roles in cell–cell and cell–extracellular matrix interactions, in cell signaling, and in biological properties of cancer cells. Their specific pattern of expression during the different steps of tumor progression toward adenocarcinoma suggests that they play significant roles in tumorigenesis. The family of secreted mucins, gel-forming components of viscoelastic mucus gels protecting the epithelia, includes mucins MUC2 and MUC6. Their principle function is to contribute in mucus formation by forming a tridimensional network via oligomerization domains to protect underlying epithelia against diverse injuries. The current study was investigated the expression of MUC2 and MUC6 in patients with gastric carcinoma. MUC2 and MUC6 expressions were detected immunohistochemically in gastric cancer biopsies using specific monoclonal antibodies. The results showed that in our gastric carcinoma cases, MUC2 expression was detected in 78.6% of cases. MUC2 expression is increased from well differentiated to moderately differentiated to poorly differentiated gastric adenocarcinoma. On the other hand, MUC6 was detected in 32% of cases. The expression of MUC2 is increasing, which is accompanied by an altered expression of MUC6 in gastric cancer. Therefore, it is concluded that the expression pattern of secreted mucins including MUC2 and MUC6 is altered apparently in gastric carcinoma.
Literature
2.
go back to reference Wang R-Q, Fang D-C. Alterations of MUC1 and MUC3 expression in gastric carcinoma: relevance to patient clinicopathological features. J Clin Pathol. 2003;56:378–84.PubMedCrossRef Wang R-Q, Fang D-C. Alterations of MUC1 and MUC3 expression in gastric carcinoma: relevance to patient clinicopathological features. J Clin Pathol. 2003;56:378–84.PubMedCrossRef
3.
go back to reference Lau SK, Weiss LM, Chu PG. Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites: an immunohistochemical study. Am J Clin Pathol. 2004;122:61–9.PubMedCrossRef Lau SK, Weiss LM, Chu PG. Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites: an immunohistochemical study. Am J Clin Pathol. 2004;122:61–9.PubMedCrossRef
4.
go back to reference Roessler K, Monig SP, Schneider PM, Hanisch FG, Landsberg S, Thiele J, Holscher AH, Dienes HP, Baldus SE. Co-expression of CDX2 and MUC2 in gastric carcinomas: correlations with clinico-pathological parameters and prognosis. World J Gastroenterol. 2005;11:3182–8.PubMed Roessler K, Monig SP, Schneider PM, Hanisch FG, Landsberg S, Thiele J, Holscher AH, Dienes HP, Baldus SE. Co-expression of CDX2 and MUC2 in gastric carcinomas: correlations with clinico-pathological parameters and prognosis. World J Gastroenterol. 2005;11:3182–8.PubMed
5.
go back to reference Kim HJ, Kim SH, Chae GB, Lee SJ, Kang CD. Increased expression of Mucin 5AC mRNA and decreased expression of epidermal growth factor receptor mRNA in gallstone patients. Tohoku J Exp Med. 2008;214:139–44.PubMedCrossRef Kim HJ, Kim SH, Chae GB, Lee SJ, Kang CD. Increased expression of Mucin 5AC mRNA and decreased expression of epidermal growth factor receptor mRNA in gallstone patients. Tohoku J Exp Med. 2008;214:139–44.PubMedCrossRef
6.
go back to reference Babu DS, Jayanthi V, Devaraj N, Reis CA, Devaraj H. Expression profile of mucins (Muc2, Muc5AC and Muc6) in Helicobacter pylori infected pre-neoplastic and neoplastic human gastric epithelium. Mol Cancer. 2006;5:1476–4598.CrossRef Babu DS, Jayanthi V, Devaraj N, Reis CA, Devaraj H. Expression profile of mucins (Muc2, Muc5AC and Muc6) in Helicobacter pylori infected pre-neoplastic and neoplastic human gastric epithelium. Mol Cancer. 2006;5:1476–4598.CrossRef
7.
go back to reference Wada R, Yamaguchi T, Tanizaki T. Mucin phenotypic expression and p53 gene abnormality of gastric superminute well differentiated adenocarcinoma. Reevaluation with relationship between histogeneis of well differentiated adenocarcinoma and intestinal metaplasia in distal stomach. J Carcinog. 2005;1:4–14. Wada R, Yamaguchi T, Tanizaki T. Mucin phenotypic expression and p53 gene abnormality of gastric superminute well differentiated adenocarcinoma. Reevaluation with relationship between histogeneis of well differentiated adenocarcinoma and intestinal metaplasia in distal stomach. J Carcinog. 2005;1:4–14.
8.
go back to reference Reis CA, David L, Carvalho F, Mandel U, de Bolos C, Mirgorodskaya E, Clausen H, Sobrinho-Simoes M. Immunohistochemical study of the expression of MUC6 mucin and co-expression of other secreted mucins (MUC5AC and MUC2) in human gastric carcinomas. J Histochem Cytochem. 2000;48:377–88.PubMedCrossRef Reis CA, David L, Carvalho F, Mandel U, de Bolos C, Mirgorodskaya E, Clausen H, Sobrinho-Simoes M. Immunohistochemical study of the expression of MUC6 mucin and co-expression of other secreted mucins (MUC5AC and MUC2) in human gastric carcinomas. J Histochem Cytochem. 2000;48:377–88.PubMedCrossRef
9.
go back to reference Lee HS, Lee HK, Kim HS, Yang HK, Kim YI, Kim WH. MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators. Cancer. 2001;92:1427–34.PubMedCrossRef Lee HS, Lee HK, Kim HS, Yang HK, Kim YI, Kim WH. MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators. Cancer. 2001;92:1427–34.PubMedCrossRef
10.
go back to reference Cornfield AP, Carroll D, Myerscough N, Probert CS. Mucins in the gastrointestinal tract in health and disease. Front Biosci. 2001;6:1321–57.CrossRef Cornfield AP, Carroll D, Myerscough N, Probert CS. Mucins in the gastrointestinal tract in health and disease. Front Biosci. 2001;6:1321–57.CrossRef
11.
go back to reference Pinto-de-Sousa J, David L, Reis CA, Gomes R, Silva L, Pimenta A. Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behavior of gastric carcinoma. Virchows Arch. 2002;440:304–10.PubMedCrossRef Pinto-de-Sousa J, David L, Reis CA, Gomes R, Silva L, Pimenta A. Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behavior of gastric carcinoma. Virchows Arch. 2002;440:304–10.PubMedCrossRef
12.
go back to reference Shiroshita H, Watanabe H, Ajioka Y. Re-evaluation of mucin phenotypes of gastric minute well differentiated type adenocarcinoma using a series of HGM, Muc5AC, Muc6, M-GGMC, Muc2 and CD10 stains. Pathol Intern. 2004;54:311–21.CrossRef Shiroshita H, Watanabe H, Ajioka Y. Re-evaluation of mucin phenotypes of gastric minute well differentiated type adenocarcinoma using a series of HGM, Muc5AC, Muc6, M-GGMC, Muc2 and CD10 stains. Pathol Intern. 2004;54:311–21.CrossRef
13.
go back to reference Songun I, van de Velde CJ, Arends JW, Blok P, Grond AJ, Offerhaus GJ, Hermans J, van Krieken JH. Classification of gastric carcinoma using the Goseki system provides prognostic information additional to TNM staging. Cancer. 1999;85:2114–8.PubMedCrossRef Songun I, van de Velde CJ, Arends JW, Blok P, Grond AJ, Offerhaus GJ, Hermans J, van Krieken JH. Classification of gastric carcinoma using the Goseki system provides prognostic information additional to TNM staging. Cancer. 1999;85:2114–8.PubMedCrossRef
14.
go back to reference Gurbuz Y, Kahlke V, Kloppel G. How do gastric carcinoma classification systems relate to mucin expression patterns? An immunohistochemical analysis in a series of advanced gastric carcinomas. Virchows Arch. 2002;440:505–11.PubMedCrossRef Gurbuz Y, Kahlke V, Kloppel G. How do gastric carcinoma classification systems relate to mucin expression patterns? An immunohistochemical analysis in a series of advanced gastric carcinomas. Virchows Arch. 2002;440:505–11.PubMedCrossRef
15.
go back to reference Reis CA, David L, Nielsen PA, et al. Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody. Int J Cancer. 1997;74:112–21.PubMedCrossRef Reis CA, David L, Nielsen PA, et al. Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody. Int J Cancer. 1997;74:112–21.PubMedCrossRef
16.
go back to reference Reis CA, David L, Correa P, Carneiro F, de Bolos C, Garcia E, Mandel U, Clausen H, Sobrinho-Simoes M. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res. 1999;59:1003–7.PubMed Reis CA, David L, Correa P, Carneiro F, de Bolos C, Garcia E, Mandel U, Clausen H, Sobrinho-Simoes M. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res. 1999;59:1003–7.PubMed
17.
go back to reference Nogueira AM, Machado JC, Carneiro F, Reis CA, Gott P, Sobrinho–Simoes M. Patterns of expression of trefoil peptides and mucins in gastric polyps with and without malignant transformation. J Pathol. 1999;187:541–8.PubMedCrossRef Nogueira AM, Machado JC, Carneiro F, Reis CA, Gott P, Sobrinho–Simoes M. Patterns of expression of trefoil peptides and mucins in gastric polyps with and without malignant transformation. J Pathol. 1999;187:541–8.PubMedCrossRef
18.
go back to reference Craanen ME, Blok P, Dekker W, Ferwerda J, Tytagt GN. Prevalence of subtypes of intestinal metaplasia in gastric antral mucosa. Dig Dis Sci. 1991;36:1529–36.PubMedCrossRef Craanen ME, Blok P, Dekker W, Ferwerda J, Tytagt GN. Prevalence of subtypes of intestinal metaplasia in gastric antral mucosa. Dig Dis Sci. 1991;36:1529–36.PubMedCrossRef
19.
go back to reference Rokkas T, Filipe MI, Sladen GE. Detection of an increased of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up. Gut. 1991;32:1110–3.PubMedCrossRef Rokkas T, Filipe MI, Sladen GE. Detection of an increased of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up. Gut. 1991;32:1110–3.PubMedCrossRef
20.
go back to reference Sakamoto H, Yonezawa S, Utsunomiya T, et al. Mucin antigen expression in gastric carcinoma of young and old adults. Hum Pathol. 1997;28:1056–65.PubMedCrossRef Sakamoto H, Yonezawa S, Utsunomiya T, et al. Mucin antigen expression in gastric carcinoma of young and old adults. Hum Pathol. 1997;28:1056–65.PubMedCrossRef
21.
go back to reference Baldus SE, Zirbes TK, Engel S, Hanisch FG, Mönig SP, Lorenzen J, Glossmann J, Fromm S, Thiele J, Pichlmaier H, Dienes HP. Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas. Int J Cancer. 1998;79:133–8.PubMedCrossRef Baldus SE, Zirbes TK, Engel S, Hanisch FG, Mönig SP, Lorenzen J, Glossmann J, Fromm S, Thiele J, Pichlmaier H, Dienes HP. Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas. Int J Cancer. 1998;79:133–8.PubMedCrossRef
22.
go back to reference Hamilton SR, Aaltonen LA. World Health Organization classification of tumors. Pathology and genetics of tumors of the digestive system. Lyon: IARC Press; 2000. p. 37–67. Hamilton SR, Aaltonen LA. World Health Organization classification of tumors. Pathology and genetics of tumors of the digestive system. Lyon: IARC Press; 2000. p. 37–67.
23.
go back to reference Dixon MF, Genta RM, Yardley H, Lorea P. Classification and grading of gastritis: the Updated Sydney System. International workshop on the histopathology of gastritis, Houton 1994. Am J Surg Pathol. 1996;20:1161–81.PubMedCrossRef Dixon MF, Genta RM, Yardley H, Lorea P. Classification and grading of gastritis: the Updated Sydney System. International workshop on the histopathology of gastritis, Houton 1994. Am J Surg Pathol. 1996;20:1161–81.PubMedCrossRef
24.
go back to reference Senapati S, Das S, Batra SK. Mucin-interacting proteins: from function to therapeutics. Trends Biochem Sci. 2010;35:236–45.PubMedCrossRef Senapati S, Das S, Batra SK. Mucin-interacting proteins: from function to therapeutics. Trends Biochem Sci. 2010;35:236–45.PubMedCrossRef
25.
go back to reference Yonezawa S, Sato E. Expression of mucin antigens in human cancers and its relationship with malignancy potential. Pathol Int. 1997;47:813–30.PubMedCrossRef Yonezawa S, Sato E. Expression of mucin antigens in human cancers and its relationship with malignancy potential. Pathol Int. 1997;47:813–30.PubMedCrossRef
26.
go back to reference Corra PA. A human model of gastric carcinogenesis. Cancer Res. 1988;48:3554–60. Corra PA. A human model of gastric carcinogenesis. Cancer Res. 1988;48:3554–60.
27.
go back to reference Reis CA, David L, Correa P, Carneiro F, de Bolos C, Garcia E, Mandel U, Clausen H, Sobrinho-Simoes M. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res. 1999;59:1003–7.PubMed Reis CA, David L, Correa P, Carneiro F, de Bolos C, Garcia E, Mandel U, Clausen H, Sobrinho-Simoes M. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res. 1999;59:1003–7.PubMed
28.
go back to reference Lesuffleur T, Zweibaum A, Real FX. Mucins in normal and neoplastic human gastrointestinal tissues. Crit Rev Oncol Hematol. 1994;17:153–80.PubMedCrossRef Lesuffleur T, Zweibaum A, Real FX. Mucins in normal and neoplastic human gastrointestinal tissues. Crit Rev Oncol Hematol. 1994;17:153–80.PubMedCrossRef
29.
go back to reference Kobayashi K, Okamoto T, Takayama S. Genetic instability in intestinal metaplasia is a frequent event leading to well differentiated early adenocarcinoma of the stomach. Eur J Cancer. 2000;36:113–9.CrossRef Kobayashi K, Okamoto T, Takayama S. Genetic instability in intestinal metaplasia is a frequent event leading to well differentiated early adenocarcinoma of the stomach. Eur J Cancer. 2000;36:113–9.CrossRef
30.
go back to reference Filipe MI, Linehan JM, Durrant LG, Price MR, Smeeton NC, Pathak S, Swallow DM. Expression of a peptide epitope of the colonic mucin MUC2 in precursor lesion to gastric carcinoma. Eur J Cancer Prev. 1996;5:287–95.PubMedCrossRef Filipe MI, Linehan JM, Durrant LG, Price MR, Smeeton NC, Pathak S, Swallow DM. Expression of a peptide epitope of the colonic mucin MUC2 in precursor lesion to gastric carcinoma. Eur J Cancer Prev. 1996;5:287–95.PubMedCrossRef
31.
go back to reference Reis CA, Sorensen T, Mandel U, David L, Mirgorodskaya E, Roepstorff P, Kihlberg J, Stig-Hansen J-E, Clausen H. Development and characterization of an antibody directed to an α-N-acetyl-D-galactosamine glycosylated MUC2 peptide. Glycoconj J. 1998;15:51–62.PubMedCrossRef Reis CA, Sorensen T, Mandel U, David L, Mirgorodskaya E, Roepstorff P, Kihlberg J, Stig-Hansen J-E, Clausen H. Development and characterization of an antibody directed to an α-N-acetyl-D-galactosamine glycosylated MUC2 peptide. Glycoconj J. 1998;15:51–62.PubMedCrossRef
32.
go back to reference De Bolos C, Garrido M, Real FX. MUC6 apomucin shows a distinct normal tissue distribution that correlates with Lewis antigen expression in the human stomach. Gastroenterology. 1995;109:723–34.PubMedCrossRef De Bolos C, Garrido M, Real FX. MUC6 apomucin shows a distinct normal tissue distribution that correlates with Lewis antigen expression in the human stomach. Gastroenterology. 1995;109:723–34.PubMedCrossRef
33.
go back to reference Ho SB, Shekels LL, Toribara NW, Kim YS, Lyftogt C, Cherwitz DL, Niehans GA. Mucin gene expression in normal, preneoplastic, and neoplastic human gastric epithelium. Cancer Res. 1995;55:2681–90.PubMed Ho SB, Shekels LL, Toribara NW, Kim YS, Lyftogt C, Cherwitz DL, Niehans GA. Mucin gene expression in normal, preneoplastic, and neoplastic human gastric epithelium. Cancer Res. 1995;55:2681–90.PubMed
34.
go back to reference Carrato C, Balague C, De Bolos C, Gonzalez E, Gambus G, Planas J, Perini JM, Andreu D, Real FX. Differential apomucin expression in normal and neoplastic human gastrointestinal tissues. Gastroenterology. 1994;107:160–72.PubMed Carrato C, Balague C, De Bolos C, Gonzalez E, Gambus G, Planas J, Perini JM, Andreu D, Real FX. Differential apomucin expression in normal and neoplastic human gastrointestinal tissues. Gastroenterology. 1994;107:160–72.PubMed
35.
go back to reference Leteurtre E, Zerimech F, Piessen G, Wacrenier A, Leroy X, Copin MC, Mariette C, Aubert JP, Porchet N, Buisine MP. Relationships between mucinous gastric carcinoma, MUC2 expression and survival. World J Gastroenterol. 2006;21:3324–31. Leteurtre E, Zerimech F, Piessen G, Wacrenier A, Leroy X, Copin MC, Mariette C, Aubert JP, Porchet N, Buisine MP. Relationships between mucinous gastric carcinoma, MUC2 expression and survival. World J Gastroenterol. 2006;21:3324–31.
36.
go back to reference Tajima Y, Shimoda T, Nakanishi Y, Yokoyama N, Tanaka T, Shimizu K, Saito T, Kawamura M, Kusano M, Kumagai K. Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: immunohistochemical analysis of 136 lesions. Oncology. 2001;61:212–20.PubMedCrossRef Tajima Y, Shimoda T, Nakanishi Y, Yokoyama N, Tanaka T, Shimizu K, Saito T, Kawamura M, Kusano M, Kumagai K. Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: immunohistochemical analysis of 136 lesions. Oncology. 2001;61:212–20.PubMedCrossRef
37.
go back to reference Machado JC, Nogueira AM, Carneiro F, Reis CA, Sobrinho-Simões M. Gastric carcinoma exhibits distinct types of cell differentiation: an immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6). J Pathol. 2000;190:437–43.PubMedCrossRef Machado JC, Nogueira AM, Carneiro F, Reis CA, Sobrinho-Simões M. Gastric carcinoma exhibits distinct types of cell differentiation: an immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6). J Pathol. 2000;190:437–43.PubMedCrossRef
38.
go back to reference Akyürek N, Akyol G, Dursun A, Yamac D, Gunel N. Expression of MUC1 and MUC2 mucins in gastric carcinomas: their relationship with clinicopathologic parameters and prognosis. Pathol Res Pract. 2002;198:665–74.PubMedCrossRef Akyürek N, Akyol G, Dursun A, Yamac D, Gunel N. Expression of MUC1 and MUC2 mucins in gastric carcinomas: their relationship with clinicopathologic parameters and prognosis. Pathol Res Pract. 2002;198:665–74.PubMedCrossRef
39.
go back to reference Wakatsuki K, Yamada Y, Narikiyo M, Ueno M, Takayama T, Tamaki H, Miki K, Matsumoto S, Enomoto K, Yokotani T, Nakajima Y. Clinicopathological and prognostic significance of mucin phenotype in gastric cancer. J Surg Oncol. 2008;2:124–9.CrossRef Wakatsuki K, Yamada Y, Narikiyo M, Ueno M, Takayama T, Tamaki H, Miki K, Matsumoto S, Enomoto K, Yokotani T, Nakajima Y. Clinicopathological and prognostic significance of mucin phenotype in gastric cancer. J Surg Oncol. 2008;2:124–9.CrossRef
40.
go back to reference Zheng HC, Li XH, Hara T, Masuda S, Yang XH, Guan YF, Takano Y. Mixed-type gastric carcinomas exhibit more aggressive features and indicate the histogenesis of carcinomas. Virchows Arch. 2008;5:525–34.CrossRef Zheng HC, Li XH, Hara T, Masuda S, Yang XH, Guan YF, Takano Y. Mixed-type gastric carcinomas exhibit more aggressive features and indicate the histogenesis of carcinomas. Virchows Arch. 2008;5:525–34.CrossRef
41.
go back to reference Kocer B, Soran A, Kiyak G, Erdogan S, Eroglu A, Bozkurt B, Solak C, Cengiz O. Prognostic significance of mucin expression in gastric carcinoma. Dig Dis Sci. 2004;49:954–64.PubMedCrossRef Kocer B, Soran A, Kiyak G, Erdogan S, Eroglu A, Bozkurt B, Solak C, Cengiz O. Prognostic significance of mucin expression in gastric carcinoma. Dig Dis Sci. 2004;49:954–64.PubMedCrossRef
42.
go back to reference Utsunomiya T, Yonezawa S, Sakamoto H, Kitamura H, Hokita S, Aiko T, Tanaka S, Irimura T, Kim YS, Sato E. Expression of MUC1 and MUC2 mucins in gastric carcinoma: its relationship with the prognosis of the patients. Clin Cancer Res. 1998;4:2605–14.PubMed Utsunomiya T, Yonezawa S, Sakamoto H, Kitamura H, Hokita S, Aiko T, Tanaka S, Irimura T, Kim YS, Sato E. Expression of MUC1 and MUC2 mucins in gastric carcinoma: its relationship with the prognosis of the patients. Clin Cancer Res. 1998;4:2605–14.PubMed
43.
go back to reference Kusano M, Kumagai K. Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: immunohistochemical analysis of 136 lesions. Oncology. 2001;61:212–20.PubMedCrossRef Kusano M, Kumagai K. Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: immunohistochemical analysis of 136 lesions. Oncology. 2001;61:212–20.PubMedCrossRef
44.
go back to reference Van der Sluis M, De Koning BA, De Bruijn AC, Velcich A, Meijerink JP, Van Goudoever JB, Büller HA, Dekker J, Van Seuningen I, Renes IB, Einerhand AW. MUC2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology. 2006;131:117–29.PubMedCrossRef Van der Sluis M, De Koning BA, De Bruijn AC, Velcich A, Meijerink JP, Van Goudoever JB, Büller HA, Dekker J, Van Seuningen I, Renes IB, Einerhand AW. MUC2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology. 2006;131:117–29.PubMedCrossRef
45.
go back to reference Hasnain SZ, Wang H, Ghia J–E, Haq N, Deng Y, Velcich A, Grencis RK, Thornton DJ, Khan WI. Mucin gene deficiency in mice impairs host resistance to an enteric parasitic infection. Gastroentrology. 2010;138:1763–71.CrossRef Hasnain SZ, Wang H, Ghia J–E, Haq N, Deng Y, Velcich A, Grencis RK, Thornton DJ, Khan WI. Mucin gene deficiency in mice impairs host resistance to an enteric parasitic infection. Gastroentrology. 2010;138:1763–71.CrossRef
46.
go back to reference Boland CR, Montgomery CK, Kim YS. Alterations in human colonic mucin occurring with cellular differentiation and malignant transformation. Proc Natl Acad Sci USA. 1982;79:2051–5.PubMedCrossRef Boland CR, Montgomery CK, Kim YS. Alterations in human colonic mucin occurring with cellular differentiation and malignant transformation. Proc Natl Acad Sci USA. 1982;79:2051–5.PubMedCrossRef
47.
go back to reference Buisine MP, Desreumaux P, Debailleul V, et al. Abnormalities in mucin gene expression in Crohn’s disease. Inflamm Bowel Dis. 1999;5:24–32.PubMedCrossRef Buisine MP, Desreumaux P, Debailleul V, et al. Abnormalities in mucin gene expression in Crohn’s disease. Inflamm Bowel Dis. 1999;5:24–32.PubMedCrossRef
48.
go back to reference Crabtree JE, Heatley RV, Losowsky MS. Glycoprotein synthesis and secretion by cultured small intestinal mucosa in coeliac disease. Gut. 1989;30:1339–43.PubMedCrossRef Crabtree JE, Heatley RV, Losowsky MS. Glycoprotein synthesis and secretion by cultured small intestinal mucosa in coeliac disease. Gut. 1989;30:1339–43.PubMedCrossRef
Metadata
Title
MUC2 and MUC6 apomucins expression in human gastric neoplasm: an immunohistochemical analysis
Authors
Abdul-Zaher M. Khattab
Wesam A. Nasif
Mahmoud Lotfy
Publication date
01-12-2011
Publisher
Springer US
Published in
Medical Oncology / Issue Special Issue 1/2011
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-010-9699-5

Other articles of this Special Issue 1/2011

Medical Oncology 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.